A previous study on spatially separated biopsies showed that methylation heterogeneity is common in GBM, though it seems to affect only the subclassification, whilst all samples remain classified as GBM IDH wildtype and MGMT methylation status also remains stable (Wenger et al., 2019). This evidence concerns the gene MGMT and glioblastoma.